2021
DOI: 10.26717/bjstr.2021.38.006117
|View full text |Cite
|
Sign up to set email alerts
|

"Is Pentraxin 3 A Marker in Pathogenesis of Metabolic Syndrome?"

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 16 publications
(17 reference statements)
0
1
0
Order By: Relevance
“…The complexity of metabolic syndrome has posed various obstacles in the management of this multifaceted health problem. Although the prevalence of metabolic syndrome has been continuously increasing for years, current pharmacological treatments have failed to provide adequate and effective treatment [2]. Obesity is defined as a persistent state of positive energy balance with excess fat buildup in the adipose tissues [3].…”
Section: Introductionmentioning
confidence: 99%
“…The complexity of metabolic syndrome has posed various obstacles in the management of this multifaceted health problem. Although the prevalence of metabolic syndrome has been continuously increasing for years, current pharmacological treatments have failed to provide adequate and effective treatment [2]. Obesity is defined as a persistent state of positive energy balance with excess fat buildup in the adipose tissues [3].…”
Section: Introductionmentioning
confidence: 99%